Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1S2OX
|
|||
| Drug Name |
Birtamimab
|
|||
| Synonyms |
NEOD001
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Al amyloidosis [ICD-11: 5D00.0] | Phase 3 | [1] | |
| Company |
Prothena Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04973137) A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects With Light Chain (AL) Amyloidosis. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.